Status:
RECRUITING
Collaboration Oriented Approach to Controlling High Blood Pressure
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
University of Missouri-Columbia
Vanderbilt University Medical Center
Conditions:
Hypertension
Multiple Chronic Conditions
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Hypertension is a significant contributor to poor cardiovascular outcomes. Self-management support tools can increase patient behaviors to improve blood pressure. The investigators created a clinical ...
Detailed Description
This protocol addresses the challenge of implementing scalable, interoperable clinical decision support (CDS) and the patient-centered outcome of avoiding heart attacks and strokes through high blood ...
Eligibility Criteria
Inclusion
- Adult patients aged 18-100 years old
- Patient receives care at a participating primary care clinic and has been seen in the last year
- Patient has high BP, defined as an average of 4 BPs \> 140 systolic or \> 90 diastolic (clinic) or \> 135 OR \> 85 (home)
- Patient is enrolled in online health portal
- Patient can communicate in English
- Patient has been recommended by their physician who thinks the patient would benefit from a home blood pressure monitoring program.
Exclusion
- Patient is pregnant at the time of consent
- Patient who, in the opinion of the primary care clinician, has severe cognitive impairment
- Patient is on hospice care and/or has a life expectancy of less than 2 years
- Patient has end stage renal disease
- Patient for whom tight blood pressure control presents a greater risk, such as those with a history of adverse events from hypertension treatment (falls, dizziness, electrolyte disturbances, hypotension, active heart failure)
- Patient has any other disease or disorder that in the opinion of the investigator or the patient's primary care clinician, could put participants at risk and affect trial results, or hinder participation will exclude them from participating
Key Trial Info
Start Date :
January 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT06124716
Start Date
January 12 2024
End Date
June 30 2026
Last Update
April 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri-Columbia
Columbia, Missouri, United States, 65211
2
Oregon Health & Science University
Portland, Oregon, United States, 97239
3
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232